Inicio › Cáncer de pulmón de células no pequeñas › Ohio › Akron
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Akron, OH
22 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Akron y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · A 21 mi de distancia
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
ReclutandoFase 3
- Akron General Medical Center, Akron
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- Aultman Health Foundation, Canton · A 21 mi de distancia
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- Aultman North, North Canton · A 15 mi de distancia
- Aultman Massillon, Massillon · A 20 mi de distancia
- Aultman Orrville Hospital, Orrville · A 21 mi de distancia
- y 2 más
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
ReclutandoFase 3
- Research Site, Canton · A 21 mi de distancia
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
ReclutandoFase 3
- Aultman Hospital, Canton · A 21 mi de distancia
Pan-tumor MRD Study
ReclutandoEstudio observacional
- Gabrail Cancer Center, Canton · A 21 mi de distancia
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ReclutandoFase 2/3
- Gabrail Cancer Center Research, Canton · A 21 mi de distancia
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
ReclutandoFase 2
- Gabrail Cancer Center, Canton · A 21 mi de distancia
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
ReclutandoFase 1/2
- Gabrail Cancer Center Research, Canton · A 21 mi de distancia
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
ReclutandoFase 2/3
- Tricounty Hematology and Oncology - Massillon, Massillon · A 20 mi de distancia
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
ReclutandoFase 3
- Gabrail Cancer Center, Canton · A 21 mi de distancia
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
ReclutandoFase 2
- Gabrail Cancer and Research Center, Canton · A 21 mi de distancia
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- Cleveland Clinic Mercy Hospital, Canton · A 21 mi de distancia
- Aultman Health Foundation, Canton · A 21 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Aultman Health Foundation, Canton · A 21 mi de distancia
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- Aultman Health Foundation, Canton · A 21 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Aultman Health Foundation, Canton · A 21 mi de distancia
GEMINI-NSCLC: NSCLC Biomarker Study
ReclutandoEstudio observacional
- Aultman Hospital, Canton · A 21 mi de distancia
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
ReclutandoFase 1
- Gabrail Cancer & Research Center, Canton · A 21 mi de distancia
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutandoFase 1/2
- Research Site 138, Canton · A 21 mi de distancia
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
ReclutandoFase 1/2
- Gabrail Cancer Center Research, Canton · A 21 mi de distancia
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
ReclutandoFase 1/2
- Gabrail Cancer Research Center, Canton · A 21 mi de distancia
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY120 estudios
- Arlington, VA104 estudios
- Nashville, TN96 estudios
- Boston, MA89 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO71 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH55 estudios
- Washington, DC54 estudios
Otros estudios en Akron
- Cáncer de pulmón16 estudios
- Cáncer (todos los tipos)14 estudios
- Cáncer de seno13 estudios
- Cáncer de próstata9 estudios
- Melanoma8 estudios
- Cáncer de pulmón de células pequeñas8 estudios
- Cáncer metastásico8 estudios
- Leucemia mielógena aguda8 estudios
- Cáncer del colon y del recto8 estudios
- Cáncer de endometrio7 estudios
- Esteatosis hepática7 estudios
- Cáncer de ovario6 estudios
De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.